Practical Considerations Managing three different compounds requires organization and attention to detail
There is currently a lack of large-scale clinical trials specifically studying the combination of prescription GLP-1 agonists and berberine supplements
studies from Asia were typically small (n=4060) and often enrolled younger patients with fewer comorbidities but more profound hepatic dysfunction at baseline, whereas Western cohorts were older, had more comorbidities, and showed evolving multi-organ failure
Management of ME/CFS As well as there being insufficient diagnostic testing available for ME/CFS patients, there are also no effective therapies (60, 488, 529531) and few established non-pharmacological treatments for ME/CFS (60), paucity of diagnostic tools (60), heterogeneity between patients (60, 529), disbelief from health care workers (60), unpredictable relapses, and multiplicity of symptoms have made it difficult to formulate a treatment for ME/CFS